Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

Author: Smorenburg C.H.   Bontenbal M.   Seynaeve C.   Zuylen C.v.   Heus G.d.   Verweij J.   Wit R.d.  

Publisher: Springer Publishing Company

ISSN: 0167-6806

Source: Breast Cancer Research and Treatment, Vol.66, Iss.1, 2001-03, pp. : 83-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content